pubmed-article:20851499 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20851499 | lifeskim:mentions | umls-concept:C0019345 | lld:lifeskim |
pubmed-article:20851499 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:20851499 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:20851499 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:20851499 | lifeskim:mentions | umls-concept:C0041582 | lld:lifeskim |
pubmed-article:20851499 | lifeskim:mentions | umls-concept:C0376249 | lld:lifeskim |
pubmed-article:20851499 | lifeskim:mentions | umls-concept:C0332237 | lld:lifeskim |
pubmed-article:20851499 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
pubmed-article:20851499 | lifeskim:mentions | umls-concept:C1522168 | lld:lifeskim |
pubmed-article:20851499 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:20851499 | pubmed:dateCreated | 2011-3-18 | lld:pubmed |
pubmed-article:20851499 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20851499 | pubmed:abstractText | Prior pilot studies support the use of antiviral medications with topical corticosteroids for herpes simplex labialis (HSL). ME-609 (Xerese, Xerclear) is a combination of 5% acyclovir and 1% hydrocortisone developed for the topical treatment of HSL. | lld:pubmed |
pubmed-article:20851499 | pubmed:language | eng | lld:pubmed |
pubmed-article:20851499 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20851499 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20851499 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20851499 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20851499 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20851499 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20851499 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20851499 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20851499 | pubmed:month | Apr | lld:pubmed |
pubmed-article:20851499 | pubmed:issn | 1097-6787 | lld:pubmed |
pubmed-article:20851499 | pubmed:author | pubmed-author:TyringStephen... | lld:pubmed |
pubmed-article:20851499 | pubmed:author | pubmed-author:LevinMyron... | lld:pubmed |
pubmed-article:20851499 | pubmed:author | pubmed-author:AokiFredF | lld:pubmed |
pubmed-article:20851499 | pubmed:author | pubmed-author:SpruanceSpots... | lld:pubmed |
pubmed-article:20851499 | pubmed:author | pubmed-author:DarpöBörjeB | lld:pubmed |
pubmed-article:20851499 | pubmed:author | pubmed-author:ArlanderEvaE | lld:pubmed |
pubmed-article:20851499 | pubmed:author | pubmed-author:HullChristoph... | lld:pubmed |
pubmed-article:20851499 | pubmed:author | pubmed-author:BringJohanJ | lld:pubmed |
pubmed-article:20851499 | pubmed:author | pubmed-author:HarmenbergJoh... | lld:pubmed |
pubmed-article:20851499 | pubmed:author | pubmed-author:ME-609... | lld:pubmed |
pubmed-article:20851499 | pubmed:copyrightInfo | Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved. | lld:pubmed |
pubmed-article:20851499 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20851499 | pubmed:volume | 64 | lld:pubmed |
pubmed-article:20851499 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20851499 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20851499 | pubmed:pagination | 696.e1-11 | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:meshHeading | pubmed-meshheading:20851499... | lld:pubmed |
pubmed-article:20851499 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:20851499 | pubmed:articleTitle | Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial. | lld:pubmed |
pubmed-article:20851499 | pubmed:affiliation | Department of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah 84132-2409, USA. Christopher.Hull@hsc.utah.edu | lld:pubmed |
pubmed-article:20851499 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20851499 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:20851499 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:20851499 | pubmed:publicationType | Multicenter Study | lld:pubmed |